This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Novel biosensor could enable fast, precise disease diagnosis and prevention

Breakthrough biosensor technology for fast and precise disease diagnosis and prevention
(a) Schematic of a vertical nanogap biosensor for label-free thrombin immunoassay, with thrombin-binding aptamer (TBA) immobilized on the metamaterial absorber (MA) structure. Top (b) and side views (c) of the SEM image. (d) Illustration of protein A/G and IgG bilayer-incubated MA structure. Credit: Biosensors and Bioelectronics (2024). DOI: 10.1016/j.bios.2024.116436

A research team affiliated with UNIST has unveiled biosensor technology that uses light to quickly and accurately detect trace amounts of proteins. This breakthrough has significant implications for preventing the spread of infectious diseases, including COVID-19.

Jointly led by Professor Jeongwon Lee in the Department of Electrical Engineering at UNIST and Dr. Joo-Yun Jung from the Nano-convergence Manufacturing Research Division at Korea Institute of Machinery and Materials (KIMM), the research team created a novel biosensor that leverages the power of surface-enhanced (SEIRS) to detect proteins in complex biological structures with unprecedented sensitivity.

The key innovation lies in the use of a metamaterial absorber that is highly responsive to mid-infrared light, allowing for accurate measurement of concentration without the need for biomarkers. The research is published in the journal Biosensors and Bioelectronics.

Unlike traditional enzyme immunoassay methods (ELISA), which rely on color changes triggered by enzymes, this new sensor detects proteins quickly and accurately without the need for additional reagents or complex procedures. This not only saves time and resources, but also opens up new possibilities for diagnosing diseases in .

The team's aptamer-based immunoassay achieved a detection limit of 267.4 pM for thrombin, a protein that plays a crucial role in blood clotting. Aptamers are highly promising alternatives to antibodies, offering improved specificity and sensitivity. The study demonstrates the potential for immunoassays using thrombin-binding aptamers to detect biomarkers with minimal time and effort.

According to Professor Lee, "Our SEIRS-based biosensor can detect even tiny amounts of protein using a strong binding effect, making it an inexpensive and rapid diagnostic tool for health care professionals."

Dr. Jung added, "The infrared metamaterial absorber-based has great potential to contribute significantly to by enabling early detection of infectious diseases."

More information: Mingyun Kim et al, Highly sensitive and label-free protein immunoassay-based biosensor comprising infrared metamaterial absorber inducing strong coupling, Biosensors and Bioelectronics (2024). DOI: 10.1016/j.bios.2024.116436

Journal information: Biosensors and Bioelectronics

Citation: Novel biosensor could enable fast, precise disease diagnosis and prevention (2024, July 24) retrieved 24 July 2024 from https://phys.org/news/2024-07-biosensor-enable-fast-precise-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples

1 shares

Feedback to editors